Case T-844/25 R: Order of the President of the General Court of 22 June 2026 – Biohaven Bioscience Ireland and Biohaven Therapeutics v EMA (Interim relief – Medicinal products for human use – Regulation (EC) No 726/2004 – Withdrawal of the application for marketing authorisation for Dazluma – Publication of the assessment report – Application for suspension of operation – Prima facie case – Urgency – Weighing up of interests)
62025TB0844 · TB · 2026-06-22 · sector 6